Lomerizine, a Ca2+ Channel Blocker, Protects against Neuronal Degeneration within the Visual Center of the Brain after Retinal Damage in Mice
Authors:
Open Access
- 5 March 2010
- journal article
- research article
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 16 (2) , 103-114
Abstract
The purpose of this study was to determine whether lomerizine, a Ca2+ channel blocker, protects against neuronal degeneration within the dorsal lateral geniculate nucleus (dLGN) and superior colliculus (SC) after the induction of retinal damage by intravitreal injection of N‐methyl‐d‐aspartate (NMDA) in mice. NMDA (20 mM/2 μL) was injected into the vitreous body of the left eye in mice (DAY 0). Lomerizine at 30 mg/kg, p.o. was administered daily from immediately after the injection of NMDA (DAY 0) to 90 days after (DAY 90). To investigate the neuroprotective effects of lomerizine, the retina, dLGN, and SC were examined using histochemistry and immunohistochemistry. Lomerizine reduced the retinal damage induced by NMDA and partially prevented the transsynaptic neuronal degeneration within dLGN and SC on the contralateral side. Moreover, lomerizine reduced the intravitreal NMDA induced decrease in the light‐induced expression of c‐Fos in the contralateral dLGN (used in this study to evaluate residual vision). These results indicate that lomerizine affords some protection against transsynaptic neuronal degeneration within the visual center of the mouse brain.Keywords
This publication has 46 references indexed in Scilit:
- Memantine Protects Against Secondary Neuronal Degeneration in Lateral Geniculate Nucleus and Superior Colliculus after Retinal Damage in MiceCNS Neuroscience & Therapeutics, 2008
- The neurobiology of cell death in glaucomaEye, 2007
- Postnatal Generation of Neurons in the Ventrobasal Nucleus of the Rat ThalamusJournal of Neuroscience, 2007
- Neuroprotective effect of calcium channel blocker against retinal ganglion cell damage under hypoxiaBrain Research, 2006
- Structural and functional composition of the developing retinogeniculate pathway in the mouseVisual Neuroscience, 2005
- Reduced cerebrovascular blood flow velocities and vasoreactivity in open-angle glaucomaAmerican Journal of Ophthalmology, 2003
- Interleukin-1β Mediates Ischemic Injury in the Rat RetinaExperimental Eye Research, 2001
- Retrograde axonal transport impairment of large- and medium-sized retinal ganglion cells in diabetic ratCurrent Eye Research, 2000
- Lomerizine (KB‐2796), a New Antimigraine DrugCNS Drug Reviews, 1995
- Absorption, distribution and excretion of 1-(bis(4-fluorophenyl)methyl)-4-(2,3,4-trimethoxybenzyl) piperazine dihydrochloride (KB-2796) after single oral administration in rats.Drug Metabolism and Pharmacokinetics, 1990